Five-year visual outcome of treatment for retinopathy of prematurity in infants weighing less than 500 g at birth: A multicenter cohort study from J-CREST.

Mizuki TomiokaTomoya MurakamiFumiki OkamotoTakamasa KinoshitaKayo ShinomiyaTomo NishiTatsuya JujoShumpei ObataHideyuki TsukitomeShuntaro OguraKaori UedaRyota IshiiTetsuro Oshika

Published in: Retina (Philadelphia, Pa.) (2023)

One-quarter of the eyes exhibited good visual acuity (Snellen BCVA of 20/20 or better) 5 years post-ROP treatment. Refractive errors were common. Anti-VEGF therapy may be superior to laser therapy in terms of myopic refractive error.

Keyphrases

stem cells
optical coherence tomography
clinical trial
combination therapy
pregnant women
cross sectional
replacement therapy
gestational age
preterm birth
quality improvement